FDA Adds Pulmonary Aspiration Warning to GLP-1 Label The FDA has recently updated the labels for all glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications used for weight loss and diabetes management, with a new safety warning
To give you an idea, here are just a few of the more common, and serious, health issues that are linked to being overweight and obese: Type 2 diabetes Cardiovascular disease, including high blood pressure and heart disease Sleep apnea Arthritis Depression Fatty liver disease Gallbladder disease Fertility issues Low testosterone Sexual dysfunction If youre overweight, youre at far greater risk for developing these conditions than someone of healthy weight
L-carnitine may also enhance energy production in cardiac cells to improve blood flow, reduce inflammation, and limit oxidative stress (an imbalance in free radicals and antioxidants that can lead to cell damage linked to aging and heart disease), she says
Silverman S Jr, Kerr AR, Epstein JB
D.GralinskiL
